Search alternatives:
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
significantly point » significantly onto (Expand Search), significantly poorer (Expand Search), significantly lower (Expand Search)
point decrease » point increase (Expand Search)
Showing 41 - 60 results of 1,716 for search '(( significant decrease decrease ) OR ( significantly point decrease ))~', query time: 0.31s Refine Results
  1. 41
    All data points from Fig 7.

    All data points from Fig 7. by Sara Hijazi (21656615)

    Published 2025
    Save to List
    Saved in:
  2. 42
    All data points from Fig 6.

    All data points from Fig 6. by Sara Hijazi (21656615)

    Published 2025
    Save to List
    Saved in:
  3. 43
    Cells lacking Cbf11 and/or Mga2 display nutrient-responsive decrease in lipid droplet (LD) content.

    Cells lacking Cbf11 and/or Mga2 display nutrient-responsive decrease in lipid droplet (LD) content. by Anna Marešová (14375187)

    Published 2024
    Save to List
    Saved in:
  4. 44
    Patient demographic information at four time points.

    Patient demographic information at four time points. by Ruitian Song (11045127)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  5. 45
    RTs (in ms, bars) and ACC (in%, line) across time points, with 95% confidence interval.

    RTs (in ms, bars) and ACC (in%, line) across time points, with 95% confidence interval. by Marcel F. Hinss (14675457)

    Published 2024
    Save to List
    Saved in:
  6. 46
    Scatter plot for the significant Mendelian randomization (MR) association (P < 0.05) between mediators and anti-H. pylori IgG seropositivity.

    Scatter plot for the significant Mendelian randomization (MR) association (P < 0.05) between mediators and anti-H. pylori IgG seropositivity. by Jing Wang (6206297)

    Published 2025
    Save to List
    Saved in:
  7. 47
    Summary of post-treatment disease course measures from MDMA-AT publications.

    Summary of post-treatment disease course measures from MDMA-AT publications. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  8. 48
    Study selection criteria.

    Study selection criteria. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  9. 49
    Summary of post-treatment CAPS score changes from clinical trials with FDA-approved medications.

    Summary of post-treatment CAPS score changes from clinical trials with FDA-approved medications. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  10. 50
    Disease course measures after the PTSD treatments.

    Disease course measures after the PTSD treatments. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  11. 51
    PICOS criteria for the SLR.

    PICOS criteria for the SLR. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  12. 52
    Summary of post-treatment CAPS score changes from MDMA-AT publications.

    Summary of post-treatment CAPS score changes from MDMA-AT publications. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  13. 53
    Summary of post-treatment disease course measures from off-label medications clinical trials.

    Summary of post-treatment disease course measures from off-label medications clinical trials. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  14. 54
    Summary of post-treatment CAPS score changes from clinical trials with psychotherapies.

    Summary of post-treatment CAPS score changes from clinical trials with psychotherapies. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  15. 55
    Summary of clinical studies of FDA-approved medications for PTSD: Disease course outcomes.

    Summary of clinical studies of FDA-approved medications for PTSD: Disease course outcomes. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  16. 56
    Summary of post-treatment disease course measures from clinical trials with psychotherapies.

    Summary of post-treatment disease course measures from clinical trials with psychotherapies. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  17. 57
    PRISMA flow chart.

    PRISMA flow chart. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  18. 58
    Summary of clinical efficacy of relevant PTSD treatments.

    Summary of clinical efficacy of relevant PTSD treatments. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  19. 59
    Post-treatment CAPS score changes from clinical trials with off-label PTSD medications.

    Post-treatment CAPS score changes from clinical trials with off-label PTSD medications. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  20. 60
    Table 1_Food scarcity and decrease in income are associated with depression after COVID-19 pandemic in rural settings.docx

    Table 1_Food scarcity and decrease in income are associated with depression after COVID-19 pandemic in rural settings.docx by Dharmendra Gahwai (20987825)

    Published 2025
    Save to List
    Saved in:

Search Tools: